INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
15/01/2026
Voltar para busca
Dado oficial do USPTO
DIOSYNTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DIOSYNTH
ST13
US500000079199948Classe
1, 5, 40, 42
Pedido
79199948
Registro
5273482
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
16/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42
Data de depósito
02/10/2015
Data de registro
29/08/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/10/2024
Última transação
16/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Tokyo, JP
Examinador
GILBERT,REBECCA L
Localização atual
Historical data usage
Titulares e representantes
Titulares
F. C. (pessoa física)
Representantes
Mainak H. Mehta Procopio Cory Hargreaves & Savitch
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations and substances for manufacturing of pharmaceutical productschemical preparations and substances for manufacturing pharmaceutical products for veterinary applications; chemical additives for manufacturing medicines; chemicals for manufacturing cosmeticsskin cleansers and medicines; chemical preservatives for pharmaceutical preparations; biochemicalspolypeptidesrecombinant proteinsorganic peptide substrates and monoclonal antibodies for producing products for genetic pharmacology
Classe 5
Medicines and pharmaceutical productsincluding medicines and pharmaceutical products for veterinary usemedicines and pharmaceutical preparations for the treatment of cardiovascular diseasecentral nervous system diseases and disordersneurological disordersurologicalurogenital disorders andgastrointestinal disordersmusculoskeletal disordersallergiesdiabeteshypertensionerectile dysfunctionsexual dysfunctionstrokecancermigrainespainobesityinflammation and inflammatory diseaserespiratory and infectious diseasesimmunologicalbacterialviral and fungal disordersmental illnessdepressionpsychosisbone and mineral diseasesinfertilitymenopausal complaintshormone deficienciessleep disorders; pharmaceutical preparationspreparations to lower cholesterolsmoking cessation preparationstissue and skin repair preparationsdermatological preparationsgynecological preparationscontraceptivesmuscle relaxantsmuscle relaxant antagonists; biotechnological preparations for medical usenamely use in gene therapy; biochemicalsbiochemical preparations for medical usenamely use in gene therapy; genetic materialgenetically engineered tissuefor transplant purposes for genetic cell therapy
Classe 40
Custom manufacture of pharmaceuticals
Classe 42
Services of biotechnicalchemical and pharmacological laboratoriesscientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations; scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparationsscientific consultation related thereto; scientific researchcarrying out early evaluations in the field of new medicines; development of pharmaceutical preparationsmedicines and medicaments; technological servicestechnological consultation and research in the field of new product development in the pharmaceutical and health care industries; scientific analysis and researchevaluation of pharmaceutical products; research and development in the pharmaceutical field; scientific research and development with regard to medicines; product developmentpreparation of pharmaceutical test products; advisory services relating to scientific researchdevelopment and analyses of medicines; development of new technologies in the biotechnology sector; providing information with regard to scientific research in the field of biochemistry and biotechnology; scientific researchincluding in the medical sector
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/12/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
08/12/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/10/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
30/06/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
31/10/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
31/10/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/10/2024
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
16/05/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22/04/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
22/08/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/01/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/08/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/01/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/12/2017
FIMP
FINAL DISPOSITION PROCESSED
13/12/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/11/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
29/08/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/06/2017
PUBO
PUBLISHED FOR OPPOSITION
13/06/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/04/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/04/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/04/2017
RFNP
REFUSAL PROCESSED BY IB
18/02/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/01/2017
RFRR
REFUSAL PROCESSED BY MPU
24/01/2017
MAFR
APPLICATION FILING RECEIPT MAILED
21/01/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/01/2017
CNRT
NON-FINAL ACTION WRITTEN
18/01/2017
DOCK
ASSIGNED TO EXAMINER
17/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/01/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
13/01/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/01/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DIOSYNTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.